Evaluation of changes in citalopram prescribing patterns following a Food and Drug Administration (FDA) alert: A retrospective cohort study

K. R. Fabo
A. M. Nye
J. P. Gagliardi
C. R. Dennis
A. J. Muzyk

Abstract